Fractyl Labs today announced the closing of a $100 million Series F financing round in addition to a name change to Fractyl Health.
Lexington, Mass.–based Fractyl Health received contributions to the round from new investors Maverick Capital, M28 Capital and Population Health Partners, while other new and existing investors participated, too.
Get the full story at our sister site, Drug Delivery Business News.